Author Archives: Cara

Screening for Familial Ovarian Cancer

More than 3,000 women with a high risk of developing ovarian cancer were enrolled in a screening study. These women were screened every year with a CA-125 blood test and … Continue reading 

Posted in News | Leave a comment

BRCA Mutation Does Not Have Effect on Long Term Survival

A study of 1,626 women with ovarian cancer showed that women with a BRCA mutation had increased survival rates at three years after diagnosis, but had the same rates of … Continue reading 

Posted in News | Leave a comment

Statement on the Passing of Senator Daniel K. Inouye

The Ovarian Cancer National Alliance sends our sympathies to the family of Daniel K. Inouye, senator of Hawaii and a long-time supporter of women with ovarian cancer. Senator Inouye was … Continue reading 

Posted in Blog | Leave a comment

Metformin May Increase Survival For Women With Ovarian Cancer

Metformin, a drug used to treat diabetes and polycystic ovarian syndrome (PCOS), may increase survival for women with ovarian cancer. A study of 239 women with ovarian cancer divided them … Continue reading 

Posted in News | Leave a comment

Study Suggests Screening Useful for High Risk Women

A study of 3,500 women at high risk of developing ovarian/fallopian cancer were screened annually for approximately three years with the CA-125 blood test and transvaginal ultrasound. In this population, … Continue reading 

Posted in News | Tagged , , | Leave a comment

Hospice Reimbursement May Disincentivize Care for Expensive Patients

A study by the Commonwealth Foundation found that patients with expensive treatment, such as palliative chemotherapy, were more likely to be turned away from hospice facilities. Some findings include The … Continue reading 

Posted in News | Tagged , , | Leave a comment

Expanding Medicaid Could Help Women with Ovarian Cancer

Many people who live near the poverty line are surprised to learn that they do not qualify for health insurance under Medicaid. Each state sets its own rules for this … Continue reading 

Posted in Blog | Leave a comment

Supreme Court to Hear Gene Patent Case

The Supreme Court of the United States will hear arguments in a case seeking to invalidate the patents on the BRCA1 and BRCA2 mutations. The patent-holder, Myriad Laboratories, owns patents … Continue reading 

Posted in News | Tagged , | Leave a comment

Dogs Sniff Ovarian Cancer

Based on funding from the Congressionally Directed Medical Research Programs, the cancer-sniffing dog training and studies continue. Read the full article here Ensure that Congress supports the Congressionally Directed Medical … Continue reading 

Posted in News | Tagged , , , , , | Leave a comment

EU Reviews Folate Receptor Drug

The European Union will review vintafolide, a folate receptor drug for ovarian cancer, made by Endocyte/Merck. The regulatory agency should make a decision in the first half of 2013. Read … Continue reading 

Posted in News | Tagged , | Leave a comment

Physiological Evidence of “Cancer Brain” Found

Using PET/CT scans, researchers looked at the brain function of 128 breast cancer patients. The study aimed to show that PET/CT is a useful tool to measure the presence of … Continue reading 

Posted in News | Tagged , , | Leave a comment

EU Approves Avastin in Combination Therapy for Recurrent Ovarian Cancer

The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer. See the article here

Posted in News | Tagged , , , , | Leave a comment